Abstract:Streptococcus suis (S. suis) is one of the important pathogens that cause bacterial meningitis in pigs and humans. Evading host immune defences and penetrating the blood-brain barrier (BBB) are the preconditions for S. suis to cause meningitis, while the underlying mechanisms during these pathogenic processes are not fully understood. By detecting the red blood and white blood cells counts, IL-8 expression, and the pathological injury of brain in a mouse infection model, a serine-rich repeat (SRR) glycoprotein, designated as SssP1, was identified as a critical facilitator in the process of causing meningitis in this study. SssP1 was exported to assemble a fimbria-like component, thus contributed to the bacterial adhesion to and invasion into human brain microvascular endothelial cells (HBMECs), and activates the host inflammatory response during meningitis but is not involved in the actin cytoskeleton rearrangement and the disruption of tight junctions. Furthermore, the deletion of sssP1 significantly attenuates the ability of S. suis to traverse the BBB in vivo and in vitro. A pull-down analysis identified vimentin as the potential receptors of SssP1 during meningitis and following Far-Western blot results confirmed this ligand-receptor binding mediated by the NR2 (the second nonrepeat region) region of SssP1. The co-localisation of vimentin and S. suis observed by laser scanning confocal microscopy with multiplex fluorescence indicated that vimentin significantly enhances the interaction between SssP1 and BBB. Further study identified that the NR216-781 and NR1711-2214 fragments of SssP1 play critical roles to bind to the BBB depending on the sialylation of vimentin, and this binding is significantly attenuated when the antiserum of NR216-781 or NR1711-2214 blocked the bacterial cells, or the vimentin antibody blocked the BBB. Similar binding attenuations are observed when the bacterial cells were preincubated with the vimentin, or the BBB was preincubated with the recombinant protein NR216-781, NR1711-2214 or sialidase. In conclusion, these results reveal a novel receptor-ligand interaction that enhances adhesion to and penetration of the BBB to cause bacterial meningitis in the S. suis infection and highlight the importance of vimentin in host-pathogen interactions. Streptococcus suis (S. suis) is considered an important zoonotic pathogen capable of causing meningitis in humans. Penetrating the blood-brain barrier (BBB) is one of the preconditions for S. suis to cause meningitis, while its underlying mechanism is incompletely understood. Here we identified a previously uncharacterised pathogenic mechanism associated with S. suis meningitis mediated by the interaction between bacterial SRR glycoproteins and a host cytoskeletal component. During the bacterial infection, SRR protein SssP1 is exported to assemble a fimbria-like component, which drives a strong binding effect with the BBB depending on the sialylation of vimentin. This interaction contributes to the bacterial adhesion to and penetration of the BBB and induces a robust inflammatory response during meningitis. This overall observation underscores the significance of host cell surface vimentin interactions in microbial pathogenesis and markedly improves our understanding of host barrier penetration during meningitis.

Interleukin-17A Contributed to the Damage of Blood-CNS Barriers During Streptococcus suis Meningitis

Interleukin-17A Contributes to Bacterial Clearance in a Mouse Model of Streptococcal Toxic Shock-Like Syndrome

The VraSR two-component signal transduction system contributes to the damage of blood-brain barrier during Streptococcus suis meningitis

The critical role of NLRP3 inflammasome activation in Streptococcus suis-induced blood-brain barrier disruption

Interleukin-1 signaling induced by Streptococcus suis serotype 2 is strain-dependent and contributes to bacterial clearance and inflammation during systemic disease in a mouse model of infection

Characteristic Comparison of Meningitis and Non-meningitis of Streptococcus Suis in an Experimentally Infected Porcine Model.

IL-18 Signaling Is Essential for Causing Streptococcal Toxic Shock-Like Syndrome (STSLS)

Potential mechanisms of Streptococcus suis virulence-related factors in blood–brain barrier disruption

EGFR Transactivation Contributes to Neuroinflammation in Streptococcus Suis Meningitis.

Purified Suilysin Secreted By Streptococcus Suis Serotype 2 Induce Interleukin-6 By Rat Brain Microvascular Endothelial Cells

SssP1, a Fimbria-like component of <i>Streptococcus suis</i>, binds to the vimentin of host cells and contributes to bacterial meningitis

Exploring the destructive synergy between IL-33 and Suilysin hemolysis on blood-brain barrier stability

Human HLA prolongs the host inflammatory response in Streptococcus suis serotype 2 infection compared to mouse H2 molecules

Selection of Potential Virulence Factors Contributing to Streptococcus suis Serotype 2 Penetration into the Blood-Brain Barrier in an In Vitro Co-Culture Model.

Meningitic Escherichia coli-Induced Interleukin-17A Facilitates Blood-Brain Barrier Disruption via Inhibiting Proteinase 3/Protease-Activated Receptor 2 Axis

Streptococcus Suis Small RNA Rss04 Contributes to the Induction of Meningitis by Regulating Capsule Synthesis and by Inducing Biofilm Formation in a Mouse Infection Model.

Roles of the Putative Type IV-like Secretion System Key Component VirD4 and PrsA in Pathogenesis of Streptococcus Suis Type 2.

O-acetyl-homoserine Sulfhydrylase Deficient Streptococcus Suis Serotype 2 Strain SC19 Becomes an Avirulent Strain and Provides Immune Protection Against Homotype Infection in Mice

Pathologic Analysis of the Brain from Streptococcus Suis Type 2 Experimentally Infected Pigs

The VraSR Regulatory System Contributes to Virulence in Streptococcus Suis Via Resistance to Innate Immune Defenses

Intranasal Immunization with Multi-virulence Factors Promotes Mucosal Clearance of Streptococcus suis across Serotypes and Protects against Meningitis in Mice.